Member Info for Aldebaran

Avacta has just doubled its cash reserves and has more to come via Coris. Not to mention we have ODD for STS plus likely for SGC which can and does come with special grants.

Oh and ontop of that their are ongoing partnering discussions taking place and company now going round confidently showcasing what they have. We know and they know they can't fund p2 so clearly CLEARLY obvious where money is coming from and not even needed until this time next year but your concerned about the next 6 months oh and the LFTs, of course. Can't forget those LFT's....

Then avacta can just so a share consolidation if we remain sub 1 dollar. I'm sure the people in charge who have been there and done this know and aren't looking for tips from bulletin boreds

What's so hard to understand that CC is following prometheus playbook. Carry on like you're going all the way and let the buyout take care of itself.

She is a Dr and wants this technology in the hands of people who can make a real difference to lives a lot quicker than avacta can. Think y'all need to wake up to what's happening here. We know the prometheus story!

Never delivered any meaningful revenue even when netzero was all the rage

Churfhelmet the problem with wyn is that his "sensible view" changes based on his trading position at the time haven't u noticed? Lol

CLN is fk all in scheme.of things. Would expect Our broker to find a home for the quarterly payments soon

Surprised to read that from so called professionals. Do they not know about the LFT debacle

Half life not an issue for ava6000 as you well know. Confirmed by Vp of chemistry Francis during R&D spotlight.

Half life of exetecan has been a problem..9hrs but now precision has extended that to 60hrs. Can you just be happy ffs

Why is nobody or no one talking about, 3996 that would be well worth patnering

Someone please PLEASE look back at my posting history for this stock. I said 5p was coming back in the 60's I think it was. Of course I was derided by the likes of red hornet and Co. Fact I'd this company Is jam tomorrow. Everything is always just around the corner but no meaningful sales materialise. The hydrogen peak has been and gone. The world is shifting back to fossil fuels. Maybe in the future this has a place but how far in the future and how much dilution are you prepared to accept?

Cash pile was reasonable last time I looked but of course with ongoing losses it will be dwindling down and another raise here won't be pretty.

Some times you just need to know when to cut your losses even if severe and get away with something. I see this going below 5p now.

Other sectors such as oncology and cancer research are never going away and used a political footballs like netzero. Much more stable sector and even more upside potential.

Thorn, saying 100x a large amount = potential side affects. Well, no m8 we'd have seen them wouldn't we.

100x small amount = it might not work, erm again, we're seeing it works aren't we.

If you still unsure, lookup the word 'vesicent'

Jeez some people on here really are desperate to spread FUD or are dum

It would be a pretty boring live webinar if we're just looking at a poster for an hour and nobody was saying anything LDA don't you think?

The year us 2032, Avacta are a multi-billion pound therapeutics company with a pipeline of cancer destroying warheads that cause negligible side affects. All ADC investment has dried up and money poured into PDC's.

Touk is still cautioning dilution for if and when avacta move to the nasdaq and Wyn remains fixated on LFT's. Most of us are no longer hanging around this bored like a bad smell as we've made our money and are off living our best lives in the sun.

New investors will hear of legends like us and wish there was some way, some signs that avacta was going to be massive

And then... it's pointed out that the underlying technology was proved to work in Humans in 2023, that they were showing complete regression of SGC metastasis and every RNS since they was better and better and better yet the price got cheaper and cheaper.

Oh why didn't I buy then they say... but you can never be too careful says Wyn, this company fked up the LFT's remember and the cycle starts again.

The market isn't going to like hydrogen it's mega expensive and peoples bills are already sky-high.

Well be pivoting back to fossil fuels in a big way soon indeed America is already moving that way

Erm.. I have hope and scientific data but if you want to always look backwards that's on you. The company has changed drastically since LFT days.

Ever look at Microsoft or Netflix or Monster energy charts and sales figures in the early days? They weren't so great. Anyone looking backwards and not forwards would have missed out big time.

Yawn

P1a dragged on because of how exceptionally good it was. Even CC and the team said this couldn't be predicted from the animal models. The company have a moral responsibility to push for an MTD as its not fair to leave any efficacy on the table.

DLT's were only just starting to be seen at almost 4x the max dose hence trial stopped.

Now as it took so long it as derisked p1b and shareholders will receive the reward for that patience. U think u can get a multi bagger without holding through some tough times u are wrong.

U are really boring and tiresome to interact with wyn. Like a raincloud on a sunny day. Here posting day in day out zzzz

LFT's, really??!

Come on Wyn drop it already. Different management team, different era I mean we don't even own that division anymore lol barring Coris which is gone soon.

Yes companies cam be flexible with there language but not with scientific data. Data that is overseen by the SAB & FDA I might add.

So if you believe the data then show me another company that has developed a drug delivery system so exquisitely targeted to FAP . You can't because.....

Avacta is unique and therefore lumping it in with other p1 biotechs that have a 90% chance of failure is wrong. That's my point.

The most potent topoisomerase inhibitor on earth and increased it's therapeutic window 75 fold?

Avacta is unique. Show me another company who has or is doing anything like avacta.

It shouldn't be priced as if it's a new drug with a 90% chance of failure

How many fail?

Why your lumping avacta in with a generic small biotech trying to develop new drugs. Avacta is unique. It is delivering existing drugs in a proven and drastically improved way.

How many can say they've taken

Boring.

The reason the company are pushing SGS is not because the other indications are pants it because SGS is fastest root to market. Once approved it then opens up off label use. It makes absolute perfect sense especially given the results.

The hole point of trials is to find stuff out and it keeps getting better and better and better so naturally avacta change with the flow..u know this ur just a permanent or are deliberately spreading fud to keep price down until the point either you or your employer want to invest. See right through you. We all do